CHHARGE

Optimizing Study Design to Test a Community-level Intervention to Reduce Intersectional Stigma and Increase HIV Testing and Prevention among African-American/Black MSM

The major goal of the study is to design and evaluate a community-level anti-intersectional stigma intervention to increase access to and uptake of HIV testing, prevention and treatment in communities of color.

Study Timeframe: 2020-2024

Principal Investigator:
Victoria Frye, DrPH

Co-investigator:
Mark Paige

Project director:
Mark Paige

Project Summary

The Columbia Collaborative HIV/AIDS Clinical Trials Unit brings together a dedicated and cohesive group of investigators and two institutions situated in New York City, one of the epicenters of the US epidemic. This collaboration includes highly experienced investigators and two successful clinical research sites with breadth and depth of expertise in clinical, translational and behavioral HIV research to be responsive to the rapidly evolving research needs in HIV prevention (including passive immunization with single, combination of multiple or multi-specific broadly neutralizing monoclonal antibodies, vaccines, novel antiretroviral-based approaches, and integrated biomedical and socio-behavioral strategies) and HIV therapeutics (including antibodies and long-acting antiretroviral formulations, and antiretroviral-free approaches to remission, biobehavioral interventions to improve adherence and reduce the risk of treatment failure, in addition to tuberculosis, complications and comorbidities), as defined by the Division of AIDS Clinical Trials Networks.

Publications:

Our projects have been supported by funding from:
NIH NIMH